PADI4 and rheumatoid arthritis: Unlike previously reports, the mean levels of anti-PAD4 antibodies and anti-PAD4/PAD3 antibody titers did increase significantly over a mean period of 22 months of follow up in our African-American cohort of patients with early RA (mean disease duration at enrollment of 15 months).